DNIB UNWIND, INC. (BIND) financial statements (2020 and earlier)

Company profile

Business Address 325 VASSAR STREET
CAMBRIDGE, MA 02139
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:374162
Cash and cash equivalents251952
Short-term investments122210
Other undisclosed cash, cash equivalents, and short-term investments(0)  
Receivables131
Prepaid expense111
Other undisclosed current assets121
Total current assets:404665
Noncurrent Assets
Property, plant and equipment1076
Long-term investments and receivables  15
Long-term investments  15
Restricted cash and investments 22
Other noncurrent assets 00
Other undisclosed noncurrent assets1  
Total noncurrent assets:10824
TOTAL ASSETS:515488
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1096
Accounts payable423
Accrued liabilities652
Employee-related liabilities 21
Debt521
Deferred revenue and credits366
Other undisclosed current liabilities (2)(1)
Total current liabilities:181412
Noncurrent Liabilities
Long-term debt and lease obligation913
Long-term debt, excluding current maturities913
Liabilities, other than long-term debt, including:304
Deferred revenue and credits314
Other liabilities11 
Other undisclosed liabilities, other than long-term debt (2) 
Other undisclosed noncurrent liabilities31 
Total noncurrent liabilities:1637
Total liabilities:341719
Stockholders' equity
Stockholders' equity attributable to parent173769
Common stock000
Additional paid in capital194177174
Accumulated other comprehensive loss(3)(3)(0)
Accumulated deficit(174)(137)(105)
Total stockholders' equity:173769
TOTAL LIABILITIES AND EQUITY:515488

Income statement (P&L) ($ in millions)

12/31/2015
12/31/2014
12/31/2013
Gross profit:151011
Operating expenses(55)(44)(38)
Operating loss:(39)(34)(27)
Nonoperating income (expense)31(0)
Investment income, nonoperating  0
Foreign currency transaction gain, before tax  0
Other nonoperating income (expense)(0)1(1)
Interest and debt expense(2)(1)(1)
Net loss:(38)(33)(28)
Other undisclosed net income attributable to parent211
Net loss attributable to parent:(37)(33)(28)
Preferred stock dividends and other adjustments  (7)
Other undisclosed net income available to common stockholders, basic  3
Net loss available to common stockholders, diluted:(37)(33)(31)

Comprehensive Income ($ in millions)

12/31/2015
12/31/2014
12/31/2013
Net loss:(38)(33)(28)
Other comprehensive loss(1)(2)(0)
Comprehensive loss:(39)(35)(29)
Other undisclosed comprehensive income, net of tax, attributable to parent211
Comprehensive loss, net of tax, attributable to parent:(37)(35)(28)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: